S430-0327 Screening compound: (3-{[1-(3-pyridylmethyl)-3-azetanyl]oxy}phenyl)(1-pyrrolidinyl)methanone

S430-0327 Screening compound: (3-{[1-(3-pyridylmethyl)-3-azetanyl]oxy}phenyl)(1-pyrrolidinyl)methanone
S430-0327 Screening compound: (3-{[1-(3-pyridylmethyl)-3-azetanyl]oxy}phenyl)(1-pyrrolidinyl)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound S430-0327
(3-{[1-(3-pyridylmethyl)-3-azetanyl]oxy}phenyl)(1-pyrrolidinyl)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S430-0327

Molecular Formula

C20H23N3O2 (C20 H23 N3 O2)

Compound Name

(3-{[1-(3-pyridylmethyl)-3-azetanyl]oxy}phenyl)(1-pyrrolidinyl)methanone

IUPAC name

n/a

SMILES

O=C(c1cc(OC2CN(Cc3cnccc3)C2)ccc1)N1CCCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

337.42

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

1.407

Distribution Coefficient, logD

0.357

Water Solubility, LogSw

-1.16

Polar Surface Area

36.963

Acid Dissociation Constant (pKa)

26.37

Base Dissociation Constant (pKb)

8.41

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

S430-0327 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S430-0327 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S430-0327?
Check Price and Availability of S430-0327, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S430-0327 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S430-0327
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S430-0327
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S430-0327 available by request